Cancer Letters, 1872-7980

Journal

More filtering options
  1. 2020
  2. ASCL1 promotes tumor progression through cell-autonomous signaling and immune modulation in a subset of lung adenocarcinoma

    Miyashita, N., Horie, M., Mikami, Y., Urushiyama, H., Fukuda, K., Miyakawa, K., Matsuzaki, H., Makita, K., Morishita, Y., Harada, H., Backman, M., Lindskog, C., Hans Brunnström, Micke, P., Nagase, T. & Saito, A., 2020, In : Cancer Letters. 489, p. 121-132 12 p.

    Research output: Contribution to journalArticle

  3. 2019
  4. Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibody

    Wu, Z., Fournel, L., Stadler, N., Liu, J., Boullier, A., Hoyeau, N., Fléjou, J. F., Duchatelle, V., Djebrani-Oussedik, N., Agopiantz, M., Ségal-Bendirdjian, E., Gompel, A., Alifano, M., Olle Melander, Trédaniel, J. & Forgez, P., 2019, In : Cancer Letters. 444, p. 147-161 15 p.

    Research output: Contribution to journalArticle

  5. 2018
  6. Montelukast, a CysLT1 receptor antagonist, reduces colon cancer stemness and tumor burden in a mouse xenograft model of human colon cancer

    Bellamkonda, K., Shakti Ranjan Satapathy, Douglas, D., Chandrashekar, N., Selvanesan, B. C., Liu, M., Savari, S., Jonsson, G. & Anita Sjölander, 2018 Nov 28, In : Cancer Letters. 437, p. 13-24 12 p.

    Research output: Contribution to journalArticle

  7. 2017
  8. Efficacy of the CDK inhibitor dinaciclib in vitro and in vivo in T-cell acute lymphoblastic leukemia

    Sausan A. Moharram, Kinjal Shah, Khanum, F., Marhäll, A., Mohiuddin, G. & Julhash U. Kazi, 2017 Oct 1, In : Cancer Letters. 405, p. 73-78 6 p.

    Research output: Contribution to journalArticle

  9. The dual specificity PI3K/mTOR inhibitor PKI-587 displays efficacy against T-cell acute lymphoblastic leukemia (T-ALL)

    Mohiuddin, G., Sausan A. Moharram, Marhäll, A. & Julhash U. Kazi, 2017 Apr 28, In : Cancer Letters. 392, p. 9-16 8 p.

    Research output: Contribution to journalArticle

  10. MicroRNAs as cancer therapeutics: A step closer to clinical application

    Catela Ivkovic, T., Gjendine Voss, Cornella, H. & Yvonne Ceder, 2017, In : Cancer Letters. 407, p. 113-122

    Research output: Contribution to journalReview article

  11. 2016
  12. Genetic variation in the major mitotic checkpoint genes associated with chromosomal aberrations in healthy humans

    Asta Försti, Frank, C., Smolkova, B., Kazimirova, A., Barancokova, M., Vymetalkova, V., Kroupa, M., Naccarati, A., Vodickova, L., Buchancova, J., Dusinska, M., Musak, L., Vodicka, P. & Kari Hemminki, 2016 Oct 1, In : Cancer Letters. 380, 2, p. 442-446 5 p.

    Research output: Contribution to journalArticle

  13. Risk of second primary cancers after malignant mesothelioma and vice versa

    Chen, T., Kharazmi, E., Lou, J., Zhang, X., Kristina Sundquist & Hemminki, K., 2016 Aug 28, In : Cancer Letters. 379, 1, p. 94-99 6 p.

    Research output: Contribution to journalArticle

  14. Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours

    Braekeveldt, N., Wigerup, C., Tadeo, I., Beckman, S., Caroline Sandén, Jönsson, J., Jonas S Erjefält, Berbegall, A. P., Anna Börjesson, Backman, T., Ingrid Øra, Navarro, S., Noguera, R., David Gisselsson, Sven Påhlman & Daniel Bexell, 2016, In : Cancer Letters. 375, 2, p. 384-389

    Research output: Contribution to journalArticle

  15. 2015
  16. Cytokeratin 20 improves the detection of circulating tumor cells in patients with colorectal cancer.

    Welinder, C., Bo Jansson, Lindell, G. & Wenner, J., 2015, In : Cancer Letters. 358, 1, p. 43-46

    Research output: Contribution to journalArticle

  17. Distribution and risk of the second discordant primary cancers combined after a specific first primary cancer in German and Swedish cancer registries.

    Chen, T., Fallah, M., Jansen, L., Castro, F. A., Krilavicuite, A., Katalinic, A., Eisemann, N., Emrich, K., Holleczek, B., Geiss, K., Eberle, A., Jan Sundquist, Brenner, H. & Kari Hemminki, 2015, In : Cancer Letters. 369, 1, p. 152-166

    Research output: Contribution to journalArticle

  18. Prognostic impact of COX-2 in non-small cell lung cancer: A comprehensive compartment-specific evaluation of tumor and stromal cell expression.

    Mattsson, J. S. M., Bergman, B., Grinberg, M., Edlund, K., Marincevic, M., Karin Jirström, Pontén, F., Hengstler, J. G., Rahnenführer, J., Karlsson, M. G., Karlsson, C., Helenius, G., Botling, J., Micke, P. & Gulyas, M., 2015, In : Cancer Letters. 356, 2, p. 837-845

    Research output: Contribution to journalArticle

  19. The α2β1 binding domain of chondroadherin inhibits breast cancer-induced bone metastases and impairs primary tumour growth: A preclinical study.

    Rucci, N., Capulli, M., Olstad, O. K., Patrik Önnerfjord, Tillgren, V., Gautvik, K. M., Heinegård, D. & Teti, A., 2015, In : Cancer Letters. 358, 1, p. 67-75

    Research output: Contribution to journalArticle

  20. 2012
  21. Co-targeting of the PI3K pathway improves the response of BRCA1 deficient breast cancer cells to PARP1 inhibition.

    Siker Kimbung, Biskup, E., Johansson, I., Kristina Aaltonen, Ottosson-Wadlund, A., Sofia Gruvberger, Cunliffe, H., Fadeel, B., Niklas Loman, Berglund, P. & Ingrid Hedenfalk, 2012, In : Cancer Letters. 319, 2, p. 232-241

    Research output: Contribution to journalArticle

  22. 2011
  23. Aberrant DNA methylation of cancer-associated genes in gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST)

    Balassiano, K., Lima, S., Jenab, M., Overvad, K., Tjonneland, A., Boutron-Ruault, M. C., Clavel-Chapelon, F., Canzian, F., Kaaks, R., Boeing, H., Meidtner, K., Trichopoulou, A., Laglou, P., Vineis, P., Panico, S., Palli, D., Grioni, S., Tumino, R., Lund, E., Bueno-de-Mesquita, H. B. & 22 others, Numans, M. E., Peeters, P. H. M., Ramon Quiros, J., Sanchez, M-J., Navarro, C., Ardanaz, E., Dorronsoro, M., Hallmans, G., Stenling, R., Ehrnström, R., Sara Regnér, Allen, N. E., Travis, R. C., Khaw, K-T., Offerhaus, G. J. A., Sala, N., Riboli, E., Hainaut, P., Scoazec, J-Y., Sylla, B. S., Gonzalez, C. A. & Herceg, Z., 2011, In : Cancer Letters. 311, 1, p. 85-95

    Research output: Contribution to journalArticle

  24. 2010
  25. Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model

    Stannard, K. A., Collins, P. M., Ito, K., Sullivan, E. M., Scott, S. A., Gabutero, E., Grice, I. D., Low, P., Nilsson, U., Hakon Leffler, Blanchard, H. & Ralph, S. J., 2010, In : Cancer Letters. 299, 2, p. 95-110

    Research output: Contribution to journalArticle

  26. 2009
  27. Concomitant use of Ad5/35 chimeric oncolytic adenovirus with TRAIL gene and taxol produces synergistic cytotoxicity in gastric cancer cells

    Lin, C., Chen, D., Gong, M., Na, M., Li, L., Wu, H., Jiang, L., Qian, Y., Fang, G. & Xue, X., 2009, In : Cancer Letters. 284, 2, p. 141-148

    Research output: Contribution to journalArticle

  28. t(3;21)(q22;q22) leading to truncation of the RYK gene in atypical chronic myeloid leukemia

    Micci, F., Panagopoulos, I., Haugom, L., Andersen, H. K., Tjonnfjord, G. E., Beiske, K. & Heim, S., 2009, In : Cancer Letters. 277, 2, p. 205-211

    Research output: Contribution to journalArticle

  29. 2008
  30. B cell lymphomas express CX(3)CR1 a non-B cell lineage adhesion molecule.

    Ulrika Andreasson, Sara Ek, Merz, H., Rosenquist, R., Andersen, N., Mats Jerkeman, Michael Dictor & Borrebaeck, C. A. K., 2008, In : Cancer Letters. 259, 2, p. 138-145

    Research output: Contribution to journalArticle

  31. Identification of differentially expressed genes after PPM1D silencing in breast cancer.

    Pärssinen, J., Alarmo, E-L., Khan, S., Karhu, R., Mauno Vihinen & Kallioniemi, A., 2008, In : Cancer Letters. 259, 1, p. 61-70

    Research output: Contribution to journalArticle

  32. Phenotypic protein profiling of different B cell sub-populations using antibody CD-microarrays

    Ellmark, P., Högerkorp, C-M., Sara Ek, Beelov, L., Berglund, M., Rosenquist, R., Christopherson, R. & Carl Borrebaeck, 2008, In : Cancer Letters. 265, p. 98-106

    Research output: Contribution to journalArticle

  33. 2007
  34. Fusion genes in angiomatoid fibrous histiocytoma

    Karolin Hansén Nord, Micci, F., Meis-Kindblom, J. M., Kindblom, L-G., Bacchini, P., Nils Mandahl, Fredrik Mertens & Panagopoulos, I., 2007 Jun 18, In : Cancer Letters. 251, 1, p. 158-163 6 p.

    Research output: Contribution to journalArticle

  35. Low dose Zebularine treatment enhances immunogenicity of tumor cells

    Liu, H., Xue, Z., Sjögren, H. O., Leif Salford & Widegren, B., 2007, In : Cancer Letters. 257, 1, p. 107-115

    Research output: Contribution to journalArticle

  36. Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation

    Zhang, H., Jin, Y., Chen, X., Jin, C., Law, S., Tsao, S-W. & Kwong, Y-L., 2007, In : Cancer Letters. 245, 1-2, p. 184-194

    Research output: Contribution to journalArticle

  37. 2006
  38. Ursodeoxycholic acid differentially affects three types of sphingomyelinase in human colon cancer Caco 2 cells.

    Liu, F., Cheng, Y., Wu, J., Tauschel, H-D. & Rui-Dong Duan, 2006, In : Cancer Letters. 235, 1, p. 141-146

    Research output: Contribution to journalArticle

  39. 2004
  40. Mitotic instability associated with late genomic changes in bone and soft tissue tumours.

    David Gisselsson Nord, Pålsson, E., Yu, C., Fredrik Mertens & Nils Mandahl, 2004, In : Cancer Letters. 206, 1, p. 69-76

    Research output: Contribution to journalArticle

  41. Profiling of internalizing tumor-associated antigens on breast and pancreatic cancer cells by reversed genomics

    Fransson, J., Sara Ek, Ellmark, P., Söderlind, E., Carl Borrebaeck & Furebring, C., 2004, In : Cancer Letters. 208, 2, p. 235-242

    Research output: Contribution to journalArticle

  42. 2003
  43. Hypoxia-induced dedifferentiation in neuroblastoma cells.

    Annika Jögi, Ingrid Øra, Helén Nilsson, Poellinger, L., Håkan Axelson & Sven Påhlman, 2003, In : Cancer Letters. 197, 1-2, p. 145-150

    Research output: Contribution to journalArticle

  44. 1999
  45. Fluorescence diagnostics and kinetic studies in the head and neck region utilizing low-dose delta-aminolevulinic acid sensitization

    Wang, I., Clemente, L. P., Pratas, R. M. G., Cardoso, E., Clemente, M. P., Montan, S., Sune Svanberg & Katarina Svanberg, 1999, In : Cancer Letters. 135, 1, p. 11-19

    Research output: Contribution to journalArticle

  46. 1998
  47. A case of dermatofibrosarcoma protuberans with a ring chromosome 5 and a rearranged chromosome 22 containing amplified COL1A1 and PDGFB sequences

    D Gisselsson, M Höglund, O'Brien, K. P., Dumanski, J. P., F Mertens & N Mandahl, 1998 Nov 27, In : Cancer Letters. 133, 2, p. 129-34 6 p.

    Research output: Contribution to journalArticle

  48. 1997
  49. Pharmacokinetic studies on 5-aminolevulinic acid-induced protoporphyrin IX accumulation in tumours and normal tissues

    Heyerdahl, H., Wang, I., Liu, D. L., Berg, R., Andersson-Engels, S., Peng, Q., Moan, J., Sune Svanberg & Katarina Svanberg, 1997, In : Cancer Letters. 112, 2, p. 225-231

    Research output: Contribution to journalArticle

  50. Tumour vessel damage resulting from laser-induced hyperthermia alone and in combination with photodynamic therapy

    Liu, D. L., Andersson-Engels, S., Sturesson, C., Katarina Svanberg, Hakansson, C. H. & Sune Svanberg, 1997, In : Cancer Letters. 111, 1-2, p. 157-165

    Research output: Contribution to journalArticle

  51. 1996
  52. 1994
  53. 1992
  54. Inhibition of leukocyte phagocytosis by serotonin and its possible role in tumor cell destruction

    Nannmark, U., Sennerby, L., Lars Magnus Bjursten, Skolnik, G. & Bagge, U., 1992, In : Cancer Letters. 62, 1, p. 83-86

    Research output: Contribution to journalArticle